𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combining capecitabine, oxaliplatin, and gemcitabine (XELOXGEM) for colorectal carcinoma patients pretreated with irinotecan: a multicenter phase I/II trial

✍ Scribed by Se Hyun Kim; Sang Joon Shin; Sun Young Kim; Se Hoon Lee; Young Suk Park; Se Hoon Park; Kyung Hee Lee; Tae Won Kim; Yong Sang Hong; Joong Bae Ahn

Publisher
Springer
Year
2011
Tongue
English
Weight
300 KB
Volume
69
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A multicenter, Phase II trial of weekly
A multicenter, Phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma
✍ Mace L. Rothenberg; John V. Cox; Russell F. DeVore; John D. Hainsworth; Richard πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 110 KB πŸ‘ 2 views

## Background: This multicenter, phase ii trial was performed to evaluate the antitumor activity and toxicity of irinotecan (cpt-11) in patients with metastatic colorectal carcinoma that had recurred or progressed after 5-fluorouracil (5-fu)-based chemotherapy. ## Methods: Cpt-11 was given as a 9

Randomized multicenter Phase II trial of
Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first-line treatment in metastatic colorectal carcinoma
✍ Emilio Bajetta; Maria Di Bartolomeo; Luigi Mariani; Antonio Cassata; Salvatore A πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 124 KB πŸ‘ 1 views

## Abstract ## BACKGROUND The aim of the current randomized Phase II study was to investigate the efficacy and safety of capecitabine combined with irinotecan as first‐line treatment in metastatic colorectal carcinoma (CRC). ## METHODS A total of 140 patients received capecitabine at a dose of 1